期刊文献+

普仑司特对实验性变应性鼻炎鼻黏膜组织重塑的影响 被引量:6

Effect of Pranlukast on tissue remodeling in experimental guinea pig allergic rhinitis model
原文传递
导出
摘要 目的观察半胱氨酸白三烯受体拮抗剂——普仑司特(pranlukast)对变应性鼻炎动物模型鼻黏膜组织重塑的影响。方法Hartley豚鼠14只,随机分为3组,即阴性对照组、卵清蛋白(ovalbumin,OVA)组和OVA+普仑司特组。OVA组:致敏的豚鼠经鼻长期OVA激发共12周;OVA +普仑司特组:致敏的豚鼠经鼻抗原激发1周后,抗原激发的同时给予普仑司特腹腔注射11周;阴性对照组仅给予生理盐水腹腔注射。标本石蜡包埋,做苏木素-伊红、阿辛蓝-过碘酸-希夫(alcian blue- periodic acid-Schiff,AB-PAS)和Masson三色胶原(Masson Trichrome,MT)染色,计数鼻中隔黏膜中的嗜酸粒细胞、上皮杯状细胞数量,半定量测量上皮细胞损伤及鼻中隔黏膜和鼻甲基底膜区及上皮下胶原含量,测定数值以x±s表示。结果与阴性对照相比,OVA组发生鼻中隔黏膜嗜酸粒细胞浸润[400倍镜下细胞数,(106.90±13.66)个/镜下]、上皮细胞损伤(完整上皮占47.25%±7.67%)、杯状细胞化生[每毫米基底膜对应上皮细胞中杯状细胞数,(22.05±5.81)个/mm]和鼻中隔黏膜及鼻甲内细胞外基质沉积明显增多;OVA+普仑司特组未见明显鼻中隔黏膜嗜酸粒细胞浸润[(8.95±2.32)个/镜下]、上皮细胞损伤(完整上皮占83.15%±8.05%),杯状细胞化生[(5.73±1.07)个/mm]以及鼻中隔黏膜及鼻甲内细胞外基质沉积。OVA+普仑司特组与阴性对照组差异无统计学意义。结论普仑司特能够阻止长期抗原激发导致的鼻黏膜组织重塑的发生,早期应用普仑司特对变应性鼻炎的治疗具有一定意义。 Objective To explore the impact of Pranlukast in nasal mucosal remodeling in experimental allergic rhinitis. Methods Foureteen male guinea pigs were randomly divided into 3 groups: control group, ovalhumin (OVA) group and OVA + Pranlukast group. In the OVA group and OVA + Pranlukast group, OVA sensitized Hartley guinea pigs were exposured intranasally to OVA for a total of 12 weeks, the OVA + Pranlukast group received additional Pranlukast treatment from the second week to the 12th week. Paraffine embeded sections were stained with hematoxylin and eosin ( HE), alcian blue-periodic acid-Schiff (AB-PAS), and Masson's Trichrome(MT). Infiltrating eosinophils, the number of goblet cells in the surface epithelium and gland cells in subepithelial nasal septal mucosa were counted. The damage of epithelium in nasal septum and extracellular matrix of nasal septal mucosa and conchae were determined. Results Compared with the control, the prolonged OVA exposure protocol caused significant pathological changes in the nasal mucosa, which included eosinophils infiltration into epithelium and submucosa( 106. 90 ±13.66), significant goblet hyperplalsia (22.05 ±5.81/mm), epithelial damage (intact epithelium: 47. 25%±7. 67% ) and deposition of extracellular matrix. These changes were significantly inhibited by Pranlukast, in which group, there were few eosinophils( 8.95 ± 2. 32) , few goblet cells(5.73±1.07/mm), and relative intact epithelium( intact epithelium: 83. 15% ± 8.05% ) , and no significant ECM deposition. Conclusions Early Pranlukast intervansion could inhibit nasal mucosal remodeling in allergic rhinitis.
作者 佘文煜 董震
出处 《中华耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2006年第7期483-487,共5页 Chinese Journal of Otorhinolaryngology Head and Neck Surgery
基金 国家"十五"科技攻关资助项目(2004BA720A19-01)
关键词 鼻炎 变应性 上皮细胞 杯状细胞 细胞外基质 普仑司特 Allergic rhinitis Epithelium Goblet cell Extracellular matrix Pranlukast
  • 相关文献

参考文献10

  • 1佘文煜,董震.实验性变应性鼻炎鼻黏膜组织重塑的特点[J].中华耳鼻咽喉头颈外科杂志,2006,41(1):48-53. 被引量:46
  • 2Ponikau JU, Sherris DA, Kephart GM, et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis : is the histopathology similar to asthma? J Allergy Clin Immunol,2003,112:877-882.
  • 3David A. Pharmacology of leukotriene receptor antagonists. Am J Respir Crit Care Med, 1998,157 : S214-219.
  • 4William R, Henderson JR, Li-Ou TANG, et al. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Med, 2002, 165 : 108-116.
  • 5Kay AB, Phipps S, Robinson DS. A role for eosinophils in airway remodelling in asthma. Trends Immunol, 2004,25:477-482.
  • 6Amin K, Rinne J, Haahtela T, et al. Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of I to 3 years' duration. J Allergy Clin Immunol,2001,107:249-257.
  • 7Rose MC, Nickola TJ, Voynow JA. Airway mucus obstruction :muein glycoproteins, MUC gene regulation and goblet cell hyperplasia. Am J Respir Cell Mol Biol, 2001,25:533-537.
  • 8Zuhdi Alimam M, Piazza FM, Selby DM, et aL Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am J Respir Cell Mol Biol, 2000, 22 :253-260.
  • 9Elias JA, Zhu Z, Chupp G, et al. Airway remodeling in asthma. J Clin Invest, 1999, 104:1001.
  • 10Asakura T, Ishii Y, Chibana K, et al. Leukotriene D4 stimulates collagen production from myofibroblasts transformed by TGF-beta. J Allergy Clin Immunol, 2004,114:310-315.

二级参考文献16

  • 1Agha-Mir-Salim P,Rauhut O,Merker HJ.Electron and fluorescence microscopic investigations on composition and structure of the epithelial basement membrane of the human inferior nasal concha.Eur Arch Otorhinolaryngol,1993,250:401-407.
  • 2Ellis R,Leigh R,Southam D,et al.Morphometric analysis of mouse airways after chronic allergen challenge.Lab Invest,2003,83:1285-1291.
  • 3Ponikau JU,Sherris DA,Kephart GM,et al.Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis:is the histopathology similar to asthma? J Allergy Clin Immunol,2003,112:877-882.
  • 4Vignola AM,Mirabella F,Costanzo G,et al.Airway remodeling in asthma.Chest,2003,123:417S-422S.
  • 5Amin K,Rinne J,Haahtela T,et al.Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years′ duration.J Allergy Clin Immunol,2001,107:249-257.
  • 6Togias A.Rhinitis and asthma:evidence for respiratory system integration.J Allergy Clin Immunol,2003,111:1171-1183.
  • 7Braunstahl GJ,Fokkens WJ,Overbeek SE,et al.Mucosal and systemic inflammatory changes in allergic rhinitis and asthma:a comparison between upper and lower airways.Clin Exp Allergy,2003,33:579-587.
  • 8Kay AB,Phipps S,Robinson DS.A role for eosinophils in airway remodelling in asthma.Trends Immunol,2004,25:477-482.
  • 9Makino S,Fukuda T.Eosinophils and allergy in asthma.Allergy Proc,1995,16:13-21.
  • 10Holgate ST,Lackie P,Wilson S,et al.Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma.Am J Respir Crit Care Med,2000,162:S113-117.

共引文献45

同被引文献78

引证文献6

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部